FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to surgery, and can be applied for local treatment of flat wounds in stage of exudative and proliferative inflammation, epithelisation of burn surface of III-A and III-B degrees as temporary wound covering. Claimed is composition for wound treatment, which contains linked bovine collagen and chitosan, differing by the fact that, as collagen, composition contains 2% solution of collagen acetate, and as chitosan it contains 2% chitosan acetate solution of medical purpose with molecular weight 100-700 kDa and degree of deacetylation over 95%, linked with glutaric aldehyde solution in final concentration 0.2%, which contains Tween-80 in final concentration 0.02%.
EFFECT: invention ensures obtaining composition from collagen and chitosan, which has reduced adhesion to wound, capable of easy removal from wound surface during bandaging, increased wound healing properties, quick and prolonged antiseptic and anaesthetising effects.
3 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BIOLOGICAL COMPOSITION TO TREAT WOUNDS | 1996 |
|
RU2108114C1 |
| WOUND COAT BASED ON COLLAGEN-CHITOSAN COMPLEX | 2003 |
|
RU2254145C1 |
| THERAPY OF DEEP BURN OF SKIN | 2008 |
|
RU2372922C1 |
| METHOD FOR OBTAINING ARTIFICIAL SKIN MATRIX | 2003 |
|
RU2252787C1 |
| COMPOSITION FOR WOUND TREATMENT AND PRODUCTS ON ITS BASIS | 2011 |
|
RU2467767C1 |
| BACTERICIDAL ANTI-BURN BIODEGRADABLE AGENT BASED ON A COLLAGEN PHARMACEUTICAL COMPOSITION WITH LACTOFERRIN, METHODS OF PRODUCING (VERSIONS) AND PROPERTIES | 2019 |
|
RU2703284C1 |
| MEANS FOR CELL REPLACEMENT THERAPY | 2007 |
|
RU2342163C1 |
| METHOD OF PREPARING SKIN CELL MATRIX | 2008 |
|
RU2391399C2 |
| SURGICAL ANTISEPTIC GLUE "ARGACOL" | 2005 |
|
RU2284824C1 |
| WOUND-HEALING COMPOSITION | 2021 |
|
RU2794958C2 |
